R ecent developments in biotechnology have resulted in a number of powerful new protein therapies for many heretofore untreatable conditions, including hepatitis C, multiple sclerosis, hormonal disorders, and different cancers. In spite of this, the use of most protein drugs is limited by the
No takes yet. Share an insight, caveat, or question.
Bartus et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: